A new Cochrane review examined 67 trials involving over 2,300 adult participants to assess the efficacy of five N-methyl-D-aspartate (NMDA) receptor antagonists — ketamine, memantine, dextromethorphan, amantadine, and magnesium — for treating chronic pain.
Study: Ketamine Has No Clear Benefit for Chronic Pain